We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Accounting Treatment Pitfalls To Avoid In Life Sciences M&A

Law360 (January 9, 2019, 2:55 PM EST) -- As M&A activity in the life sciences industry continues to be strong, driven by big pharma divestitures of off-strategy drugs, buyers hoping to develop acquired products into profitable assets must use...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.